Amelioration of insulin resistance in diabetic ob/ob mice by a new type of orally active insulin–mimetic vanadyl complex: Bis(1-oxy-2-pyridinethiolato)oxovanadium(IV) with VO(S2O2) coordination mode
- 11 June 2001
- journal article
- Published by Elsevier in Journal of Inorganic Biochemistry
- Vol. 85 (2-3) , 179-186
- https://doi.org/10.1016/s0162-0134(01)00192-1
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Effects of vanadyl sulfate on carbohydrate and lipid metabolism in patients with non—insulin-dependent diabetes mellitusMetabolism, 1996
- Oral vanadyl sulfate improves insulin sensitivity in NIDDM but not in obese nondiabetic subjectsDiabetes, 1996
- Orally Active and Long-Term Acting Insulin-Mimetic Vanadyl Complex: Bis(Picolinato)oxovanadium(IV)Biochemical and Biophysical Research Communications, 1995
- Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance.Journal of Clinical Investigation, 1995
- Tumor necrosis factor alpha: a key component of the obesity-diabetes linkDiabetes, 1994
- Vanadate treatment of diabetic rats reverses the impaired expression of genes involved in hepatic glucose metabolism: Effects on glycolytic and gluconeogenic enzymes, and on glucose transporter GLUT2Molecular and Cellular Endocrinology, 1993
- Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin ResistanceScience, 1993
- Insulin-like effect of vanadyl ion on streptozotocin-induced diabetic ratsJournal of Endocrinology, 1990
- Inhibition of membrane phosphotyrosyl-protein phosphatase activity by vanadateBiochemical and Biophysical Research Communications, 1982
- Detection of oxovanadium(IV) and characterization of its ligand environment in subcellular fractions of the liver of rats treated with pentavalent vanadium(V)Biochemical and Biophysical Research Communications, 1980